Compound information
- Natural Products
- ZC1365415
- Molecular Formula
- C13H16Cl2N2O3S
- Molecular Weight
- 350.025868732 g/mol
- Structure
-
- IUPAC Name
- 2-chloro-N-[4-chloro-3-(1-piperidylsulfonyl)phenyl]acetamide
- InChI
- InChI=1S/C13H16Cl2N2O3S/c14-9-13(18)16-10-4-5-11(15)12(8-10)21(19,20)17-6-2-1-3-7-17/h4-5,8H,1-3,6-7,9H2,(H,16,18)
- InChI Key
- NMKMSYQBPDKDDV-UHFFFAOYSA-N
- SMILES
- O=C(CCl)Nc1ccc(Cl)c(S(=O)(=O)N2CCCCC2)c1
- Source
- ZINC000008264109
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 21 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 1 |
Topological Polar Surface Area | 66.48 Å2 | LogP | 2.809 |
LogS | -4.137 | LogD | 2.492 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.036 | Pgp substrate | 0.008 |
HIA | 0.97 | F20 % | 0.992 |
F30 % | 0.969 | Caco-2 | -5.391 |
MDCK | -4.741 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.684 | PPB | 98.03 |
VD | 1.105 | Fu | 1.103 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.982 | CYP1A2 substrate | 0.611 |
CYP2A6 substrate | 0.68 | CYP2B6 substrate | 0.621 |
CYP2C19 inhibitor | 0.948 | CYP2C19 substrate | 0.858 |
CYP2C8 substrate | 0.752 | CYP2C9 inhibitor | 0.576 |
CYP2C9 substrate | 0.444 | CYP2D6 inhibitor | 0.186 |
CYP2D6 substrate | 0.548 | CYP2E1 substrate | 0.315 |
CYP3A4 inhibitor | 0.551 | CYP3A4 substrate | 0.991 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.335 | CL | 9.139 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.486 | Hepatotoxicity | 0.936 |
Mutagenicity | 0.057 | Rat Oral Acute Toxicity | 0.198 |
FDAMDD | 0.466 | Skin Sensitization | 0.81 |
Carcinogenicity | 0.111 | Eye Corrosion | 0.028 |
Eye Irritation | 0.019 | Respiratory Toxicity | 0.916 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.613 | IGC50 | 4.391 |
LC50FM | 4.314 | LC50DM | 4.681 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.094 | NR-AR-LBD | 0.514 |
NR-AhR | 0.477 | NR-Aromatase | 0.878 |
NR-ER | 0.457 | NR-ER-LBD | 0.627 |
NR-PPAR-gamma | 0.903 | SR-ARE | 0.981 |
SR-ATAD5 | 0.659 | SR-HSE | 0.81 |
SR-MMP | 0.638 | SR-p53 | 0.851 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.